SIRT6 and cancer: Here we explored the molecular and biological effects of this compound in cancer cell lines of different origin, including non-small cell lung, colon and epithelial cervix carcinoma, and fibrosarcoma, clearly demonstrating that pharmacological SIRT6 activation triggers an autophagy-related cell death.